The summer of 2019 was dreadful for the cannabis sector generally, and CBD stocks were no exception to this. Still, ever since the 2018 Farm Bill was signed into law last December - effectively legalizing the growing of industrial hemp for CBD and other purposes - I've stayed the course on my bullish outlook for cannabidiol products.

The CBD market is already valued at $591 million since being legalized in the United States; the Brightfield Group says this figure will soar to $22 billion by 2022. You can now buy CBD edibles, oils, lotions, beverages, and more. Walgreen’s and CVS have CBD products on their shelves. In some restaurants, it’s even served in salad dressings.

Furthermore, the FDA (Food and Drug Administration) recently announced that it will speed up efforts to create rules for CBD with plans to publish a report on its progress by early fall. With all this in mind, I'm prepared to share my top five CBD stocks, any or all of which could propel the niche back to favored status among investors.

My biggest pick for CBD exposure now is Cronos Group (CRON), which struck a $100 million deal with Ginkgo Bioworks to create unique CBD products. Also keep in mind that one of the world’s largest tobacco companies, Altria Group, invested $1.8 billion in cash into Cronos in March. Therefore, Cronos will be able to increase its investments into CBD products and branding.

Another pick for CBD exposure is good old Canopy Growth Corp. (CGC), which has filed for U.S. trademarks for potential brand names including CBD Simplified, CB-Tea, Hemp Break, and Hemp Burst. Furthermore, Constellation Brands owns a 38% stake in Canopy Growth and is partnering with the company to develop and market cannabis-related products, which should provide a boost to the CBD market.

My third choice is Charlotte’s Web (CWBHF), a company that markets a wide range of CBD products, including oils, capsules, creams, and pet products. This company already has the number-one hemp CBD brand in the country, and they plan to more than double the acres of hemp they’re planting this year. Plus, Charlotte’s Web now ships to more than 6,000 retail locations across the U.S., with over 2,300 of those added this year.

My fourth choice is Green Growth Brands (GGBXF), which has landed a number of major retail partnerships for its Seventh Sense line of CBD-infused products. They have partnerships with Abercrombie & Fitch, American Eagle Outfitters, Simon Property Group (the largest mall operator in the U.S.), and shopping center operator Brookfield Properties. Therefore, you might see Green Growth Brands’ CBD products in a large number of malls and shopping centers in the near future.

The fifth and final CBD pick on my list is Aurora Cannabis (ACB), which has leveraged its enormous purchasing power to subsume a number of strategically targeted hemp-focused companies. Among Aurora’s most recent and noteworthy acquisitions are hemp-based product provider Hempco Food and Fiber and South American hemp cultivator ICC Labs, both of which can position Aurora as a prolific purveyor of CBD-rich cannabis product.

As I see it, with the mainstreaming of CBD will come great wealth; feel free to accumulate any or all of these hemp stocks to partake of the green days ahead.